Nachrichten

Le Temps (17.05.2021) - Meinung. Die Schweizer Vermögensverwaltung, die manchmal als traditionell, um nicht zu sagen «altmodisch» dargestellt wird, hat sich einmal mehr als agile und innovative Branche erwiesen, die ihre Führungsposition behaupten kann.

Raconteur (The Wealth Management 2021 report published in The Sunday Times - 16.05.2021) - The health of our planet is intimately linked to your pension and your long-term financial goals, says Victoria Leggett, Head of Impact Investing at UBP.

Finanz und Wirtschaft (19.01.2021) - Norman Villamin, CIO Wealth Management von Union Bancaire Privée, hält die Furcht vor deutlich höheren  Zinsen für verfrüht. Er zieht Bergbautitel den Bankaktien vor.

Institutional Money (06.05.2021) - In den vergangenen Monaten sind die Nominalzinsen weltweit gestiegen. Dieser Trend wird unserer Einschätzung nach andauern, allerdings aus anderen Gründen. Damit stellt sich die Frage, wie sich Anleger nun an den Rentenmärkten positionieren sollten.

Japan’s equity markets have outpaced other major developed market equities in both 2020 and year-to-date in 2021 as the world seeks to transition to a post-pandemic recovery.

Hubbis (03.04.2021) – Hubbis recently spoke with Michael Blake, CEO UBP Asia, as he cast his eye over the regional wealth management market and explained why he and UBP remain so optimistic about private banking in the region.

The first quarter of 2021 was positive for most asset classes. However, financial markets were far from calm.

We are introducing a new monthly podcast series on foreign exchange.

L'Agefi (23.04.2021) – Union Bancaire Privée is on a continuous growth trajectory integrating sustainability criteria. We interviewed Nicolas Faller, the bank’s Co-CEO Asset Management.

Asia Macro - China: Domestic demand takes over for the next leg of the recovery

PWM (08.04.2021) – Union Bancaire Privée’s Michael Blake discusses the importance of an integrated investment banking and wealth management model for servicing wealthy families

UBP talks to Stéphane Bancel, Moderna CEO, to learn how the mRNA technology not only made one of the first COVID-19 vaccines possible, but, more importantly for investors, has the potential to disrupt the broader pharmaceutical industry in its wake.